Distribution of Epstein-Barr virus in systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis) with associated lymphadenopathy: A study of 49 cases

International Journal of Surgical Pathology

Volumn 13, Issue 3, 2005, Pages 273-278

  Kojima, Masaru ^a,b   Motoori, Tadashi ^c   Itoh, Hideaki ^d   Shimizu, Kazuhiko ^e   Iijima, Misa ^a   Tamaki, Yoshio ^a   Murayama, Kayoko ^a   Ohno, Yoshihiro ^f   Yoshida, Katsue ^g   Masawa, Nobuhide ^b   Nakamura, Shigeo ^h  

^a GUNMA CANCER CENTER HOSPITAL   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY MEDICAL CENTER   (Japan)

^d MAEBASHI RED CROSS HOSPITAL   (Japan)

^e ASHIKAGA RED CROSS HOSPITAL   (Japan)

^f Tone Central Hospital   (Japan)

^g Kiryu Kosei General Hospital   (Japan)

^h NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Dermatomyositis; Epstein Barr virus; In situ hybridization; Reactive lymphoproliferative lesion; Rheumatoid arthritis; Systemic lupus erythematous; Systemic rheumatic disease

Indexed keywords

METHOTREXATE; RNA; VIRUS RNA;

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DERMATOMYOSITIS; DNA EXTRACTION; EPSTEIN BARR VIRUS; FEMALE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IN SITU HYBRIDIZATION; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE DISTRIBUTION; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODES; LYMPHATIC DISEASES; MALE; MIDDLE AGED; RHEUMATIC DISEASES; RNA, VIRAL;

EID: 23644454252     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690501300307     Document Type: Article

References (27)

1. Henry K. Connective tissue disorders/autoimmune diseases. In Henry K, Symmers WStC (eds): Thymus, lymph nodes, spleen and lymphatics. Systemic pathology, 3rd ed. vol. 7. Churchill Livingstone, Edinburgh, pp. 255-263, 1992
2. Kojima M, Hosomura Y, Itoh H, Johshita T, Yoshida K, Nakamura S, Suchi T. Reactive proliferative lesions in lymph node from rheumatoid arthritis patients. A clinicopathological study and immunohistochemical study. Acta Pathol Jpn 40:249-254, 1990
3. Kojima M, Nakamura S, Morishita Y, Itoh H, Yoshida K, Ohno Y, Oyama T, Asano S, Joshita T, Mori S, Suchi T, Masawa N. Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients. A clinicopathological study of 21 cases. Pathol Int 50:304-312, 2000
4. Koo CH, Nathwani BN, Winberg CD, Hill LR, Rappaport H. Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmune-disease-associated lymphadenopathy. Medicine (Baltimore) 63:274-290, 1984
5. Blanco R, McLaren B, Davis B, Steele P, Smith R. Systemic lupus erythematosus-associated lymphoproliferative disorder: Report of a case discussion in light of the literature. Hum Pathol 28:980-985, 1997
6. Koima M, Nakamura S, Yamane Y, Tanaka H, Masawa N. Autoimmune disease-associated lymphadenopathy from dermatomyositis. A case report. Pathol Res Pract 199:691-694, 2003
7. Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25:638-643, 1994
8. Kamel OW, Weiss LM, van de Rijin, Colby TV, Kingma DW, Jaffe ES. Hodgkin's disease in patients with long-term low-dose methotrexate therapy. Am J Surg Pathol 20:1279-1287, 1996
9. Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Grouch J, Shultz M, Murren J. Spontaneous regression of lymphoproliferative disorders in patients with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14:1943-1949, 1996
10. Kamel OW. Iatrogenic lymphoproliferative disorders in nontransplantation setting. Semin Diag Pathol 14:27-34, 1997
11. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 12:200-217, 1999
12. Harris NL, Swerdlow SH. Methotrexate-associated lymphoproliferative disorders. In Jaffe ES, Harris NL, Stein H, Vardiman JW (eds): Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp. 270-271, 2003
13. Ioachim HL. Ioachim's Lymph node pathology, 3rd ed. JB Lippincott, Philadelphia, pp. 261-263, 2003
14. Kojima M, Nakamura S, Itoh H, Yoshida K, Suchi T, Masawa N. Lymph node necrosis in systemic lupus erythematosus. A histopathological and immunohistochemical study of four cases. APMIS 109:141-146, 2001
15. Kojima M, Nakamura S, Oyma T, Motoori T, Itoh H, Yoshida K, Suchi T, Masawa N. Autoimmune disease-associated lymphadenopathy with histologic appearance of T-zone dysplasia with hyperplastic follicles. A clinicopathologic analysis of nine cases. Pathol Res Pract 197:237-244, 2001
16. Kojima M, Nakamura S, Itoh H, Shimizu K, Murayama K, Iijima M, Hosomur Y, Ohno Y, Yoshida K, Mtoori T, Sakata N, Masawa N. Clinical implication of florid reactive follicular hyperplasia in Japanese patients 60 years or older. A study of 46 cases. Int J Surg Pathol 13, 2005 (in press)
17. Trainor KJ, Brisco MJ, Was JH, Neoh S, Grist S, Moriey AA. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood 78:192-196, 1991
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
19. Kumar V, Corton RS, Robbins SL. Basic pathology, 7th ed. WB Saunders, Philadelphia, pp. 103-164, 2003
20. Hochberg MC. Updating the American Colledge of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725, 1997
21. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-347, 1975
22. Flendrig JA. Benign giant lymphoma: clinicopathologic correlation study. In Clark RL, Gumley RW (eds): The year book of cancer. Year Book Medical Publishers, Chicago, pp. 296-299, 1970
23. Osborne BM, Butler JJ, Viriakojis D, Kott M. Reactive lymph node hyperplasia with giant follicles. Am J Clin Pathol 78:493-499, 1982
24. Kurth J, Hansmann M-L, Rajewsky K, Küppers R. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in germinal center reaction. Proc Natl Acad Sci USA 100:4730-4735, 2003
25. Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, Rickinson AB, Stein H. Patterns of Epstein-Barr virus infection in nonneoplastic lymphoid tissue. Blood 79:2520-2526, 1992
26. Deamant FD, Albúgar PF, Chen Y-Y, Weiss LM. Epstein-Barr virus distribution in nonneoplastic lymph nodes. Mod Pathol 6:729-732, 1993
27. Kobayashi R, Takeuchi H, Sasaki M, Hasegawa M, Hirai K. Detection of Epstein-Barr virus infection in the epithelial cells and lymphocytes of nonneoplastic tonsils by in situ hybridization and in situ PCR. Arch Virol 143:803-813, 1999